Zusammenfassung
Aus der pluripotenten Stammzelle des Knochenmarks entwickeln sich über drei verschiedene Differenzierungsreihen Granulozyten, Erythrozyten und Thrombozyten. Im Proliferations- und Reifungsprozeß der thrombozytären Reihe, der beim Gesunden ca. 10 Tage dauert, bilden sich aus den Stammzellen über Megakaryoblasten die Megakaryozyten (Baldini u. Ebbe, 1974; Wintrobe, 1974; Begemann, 1975). Nach Endoreduplikation des Kerns, wobei Megakaryozyten unterschiedlicher Kernploidie (4 N–32 N) (Paulus, 1971) entstehen, reift das Zytoplasma unter Bildung von Zellorganellen und Demarkierung in zytoplasmatische Untereinheiten (Yamada, 1957). Am Ende des Reifungsvorganges werden diese ZytoplasmaFragmente eines Megakaryozyten fast gleichzeitig als Thrombozyten direkt in den Kreislauf abgegeben (Kinosita u. Ohno, 1961; De Bruyn, 1964).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aas, K.A., Gardner, F.H.: Survival of blood platelets labeled with Chromium51. J. clin. Invest. 32, 1257–1268 (1958).
Abrahamsen, A.F.: The effect of EDTA and ACD on the recovery and survival of Cr51-labeled blood platelets. Scand. J. Haemat. 2, 52–60 (1965).
Abrahamsen, A.F.: Platelet survival studies in man. With special reference to thrombosis and atherosclerosis. Scand. J. Haemat., Suppl. 3, (1968).
Abrahamsen, A.F.: Platelet survival in Hodgkin’s disease. Scand. J. Haemat. 7, 309–313 (1970).
Abrahamsen, A.F.: The effects of acetylsalicylic acid and dipyridamole on platelet economy in metastatic cancer. Scand. J. Haemat. 9, 562–565 (1972a).
Abrahamsen, A.F.: Effects of an enlarged splenic platelet pool in Hodgkin’s disease. Scand. J. Haemat. 9, 153–158 (1972b).
Abrahamsen, A.F., Eika, C., Godal, H.C., Lorentsen, E.: Effect of acetylsalicylic acid and dipyridamole on platelet survival and aggregation in patients with atherosclerosis obliterans. Scand. J. Haemat. 13, 241–245 (1974).
Adelson, E., Kaufman, R.M., Lear, A.A., Kirby, J.C., Rheingold, J.J.: Physiology of platelet destruction as revealed by tagging of cohorts. I. Studies in dogs. J. Lab. clin. Med. 62, 385–393 (1963).
Anderson, O., Tissot, R., Cohen, C., Jonasson, O.:Platelet survival in rabbits to detect hyperacute rejection. J. Surg. Res. 14, 193–199 (1973).
Aster, R.H.: Effect of Anticoagulant and ABO Incompatibility on Recovery of Transfused Human Platelets. Blood 26, 732–743 (1965).
Aster, R.H.: Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia. J. clin. Invest. 45, 645–657 (1966).
Aster, R.H.: Platelet sequestration studies in man. Brit. J. Haemat. 22, 259.-263 (1972).
Aster, R.H., Jandl, J.H.: Platelet sequestration in man. I. Methods. J. clin. Invest. 43, 843–855 (1964a).
Aster, R.H., Jandl, J.H.: Platelet sequestration in man. II. Immunological and clinical studies. J. clin. Invest. 43, 856–869 (1964b).
Aster, R.H., Keene, W.R.: Sites of platelet destruction in idiopathic thrombocytopenic purpura. Brit. J. Haemat. 16, 61–73 (1969).
Baldini, M.: Idiopathic thrombocytopenic purpura. New Engl. J. Med. 274, 1245–1251 (1966).
Baldini, M.G., Ebbe, S.: Platelets: production, function, transfusion and storage. New York: Grune & Stratton 1974.
Barkhan, P.: Platelet survival studies in man with diisopropylphosphofluoridate (DF32P). Some observations in patients with hypocoagulability, hypercoagulability and platelet disorders. Brit. J. Haemat. 12, 25–36 (1966).
Begemann, H. (Hrsg.): Klinische Hämatologie. 2. Auflage. Stuttgart: Thieme 1975.
Begemann, H., Harwerth, H.-G.: Praktische Hämatologie. 6. Auflage. Stuttgart: Thieme 1974.
Beuerlein, I., Mariss, P., Stangel, W.: Untersuchungen mit radioaktiv markierten Eigen- und Fremdthrombozyten zur Ermittlung von Überlebensdauer und Abbauort. Nucl.-Med. (Stuttg.) 14, 240–247 (1975).
Bhowal, S.C., Maheshwari, H.B., Kumar, S.: The haematologic functions of lung. II. The role of lung in the release of platelets into circulation. Indian. J. Path. Bact. 9, 303–312 (1966).
Bleifeld, W., Gehrmann, G.: Über die Bedeutung der radioaktiven Markierung von Thrombozyten mit 51Cr in der Diagnostik von Thrombozytopenien. Dtsch. med. Wschr. 91, 1594 1599 (1966).
Bottiger, L.E., Edhag, O., Forsgren, L.: Splenectomy–indications and results. Acta med. scand. 192, 213–219 (1972).
Branehög, J., Kutti, J., Ridell, B., Swolin, B., Weinfeld, A.: The relation of thrombokinetics to bone marrow megakaryocytes in idiopathic thrombocytopenic purpura (ITP). Blood 45, 551–562 (1975).
Branehög, J., Kutti, J., Weinfeld, A.: Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP). Brit. J. Haemat. 27, 127–143 (1974).
Branehög, J., Weinfeld, A.: Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP) before and during treatment with corticosteroids. Scand. J. Haemat. 12, 69–79 (1974).
Branehög, J., Weinfeld, A., Roos, B.: The exchangeable splenic platelet pool studied with epinephrine infusion in idiopathic thrombocytopenic purpura and in patients with splenomegaly. Brit. J. Haemat. 25, 239–248 (1973).
Breddin, K.: Die Thrombocyten. Dtsch. med. J. 22, 766–770 (1971).
Breslov, A., Kaufman, R.M., Lawsky, A.R.: The effect of surgery on the concentration of circulating megakaryocytes and platelets. Blood 32, 393–401 (1968).
Brodie, G.N., Firkin, B.G.: Platelet life span in patients with valvular heart disease and Starr-Edwards prostheses. Med. J. Aust. 1, 453–455 (1972).
Brodsky, J., Ross, E.M., Petkov, G., Kahn, S.B.: Platelet and fibrinogen kinetics with (75Se)-Selenomethionine in Patients with myeloproliferative Disorders. Brit. J. Haemat. 22, 179–192 (1972).
Brodsky, J., Siegel, N.H., Kahn, S.B., Ross, E.M., Petkov, G.: Simultaneous fibrinogen and platelet survival with (75Se) selenomethionine in man. Brit. J. Haemat. 18, 341–355 (1970).
Canellos, G.P., Nordland, J., Carbone, P.P.: Splenectomy for thrombocytopenia in chronic granulocytic leukemia. Cancer 29, 660–665 (1972).
Carruthers, J.A., Ralfs, J., Gimlette, T.M.D.,Finn, R.: Platelet survival in acute proliferative glomerulonephritis. Clin. Sci. Mol. Med. 47, 507–513 (1974).
Castaldi, P.A., Firkin, B.G.: Studies of the life span and fate of platelets. Aust. NZ. J. Med. form. Austral. Ann. Med. 12, 333–341 (1963).
Cesareo, R.: Medical applications of radioisotope induced x-ray fluorescence. 13. Jahrestagung Ges. Nuklearmedizin, Kopenhagen 1975.
Choi, S.I., Simone, J.V.: Platelet production in experimental iron deficiency anaemia. Blood 42, 219–228 (1973).
Cohen, P., Cooley, M.H., Gardner, F.H.: The use of selenomethionine (Se’s) as a label for canine and human platelets. J. clin. Invest. 44, 1036–1037 (1965)
Cohen, P., Gardner, F.H.: Thrombocytopenia as a laboratory sign and complication of gram-negative bacteremic infection. Arch. intern. Med. 117, 113–124 (1966).
Cohen, P., Gardner, F.H., Barnett, G.O.: Reclassification of the thrombocytopenias by the CI-s1-labeling method for measuring platelet life span. New Engl. J. Med. 264, 1294–1299 (1961).
Cooney, D.P., Smith, B.A.: The pathophysiology of hypersplenic thrombocytopenia. Arch. intern. Med. 121, 332–337 (1968).
Cooney, D.P., Smith, B.A., Fawley, D.E.: The use of di-isopropylfluorophosphate (32DFP) as a platelet label: evidence for reutilization of this isotope in man. Blood 31, 791–805 (1968).
Cooper, W.: Pancytopenia associated with disseminated tuberculosis. Ann. Med. Interne (Paris) 50, 1497 (1959).
Cooper, M.R., Hansen, K.S., Maynard, C.D., Elrod, I.W., Spurr, C.L.: Platelet survival and sequestration patterns in thrombocytopenic disorders. Radiology 102, 89–100 (1972).
Cowan, D.H.: Thrombokinetic studies in alcohol-related thrombocytopenia. J. Lab. clin. Med. 81, 64–75 (1973a).
Cowan, D.H.: Thrombokinetics in acute nonlymphytic leukemia. J. Lab. clin. Med. 82, 911–923 (1973b).
Cowan, D.H., Hines, J.D.: Thrombokinetics in dietary-induced folate deficiency in human subjects. J. Lab. clin. Med. 81, 577–586 (1973).
Dabels, J., Preussner, S., Konrad, H., Schulz, K., Engelmann, C., Claus, R.: Blutgerinnungsuntersuchungen bei essentiellen Hyperlipoproteinämien unter besonderer Berücksichtigung der Thrombozytenkinetik. Folia haemat. (Lpz.) 101, 833–841 ( 1974.
Dameshek, W.: Hypersplenism. Bull. N.Y. Acad. Med. 31, 113–119 (1955).
Davey, M.G.: The survival and destruction of human platelets. Basel: S. Karger 1966.
Davey, M.G., Lander, H.: The labelling of human platelets with radiochromate. Aust. J. exp. Biol. med. Sci. 41. 581 (1963).
Davis, W.M., Mendez Ross, A.O.: Thrombocytosis and Thrombocythemia: The Laboratory and Clinical Significance of an Elevated Platelet Count. Amer. J. clin. Path. 59, 243–247 (1973).
Debruyn, P.P.: The fine structure of the megakaryocyte of the bone marrow of the guinea pig. Z. Zellforsch. 64, 111–118 (1964).
Dechavanne, M., Berthoux, F., Thouverez, J.-P., Arnaud, Ph., Viala, J.-J.: Etude de la cinétique des plaquettes et du fibrinogène par marquage radioisotopique dans les cirrhoses splénomégaliques avec thrombopénie. Path. et. Biol. 20, 127–130 (1972).
Degabriele, G., Penington, D.G.: Regulation of platelet production: “thrombopoietin”. Brit. J. Haemat. 13, 210–215 (1967).
Dimitrow, L., Oreschkow, W., Nikolow, T., Milew, A.: Radiometrische Indizes und Splenektomie bei der Leberform der essentiellen Thrombopenie. Blut 26, 134–140 (1973).
Doan, C.A.: Hypersplenism. Bull. N.Y. Acad. Med. 25, 625–650 (1949).
Doan, C.A., Bouroncle, B.A., Wiseman, B.K.: Idiopathic and secondary thrombocytopenic purpura: Clinical study and evaluation of 381 cases over a period of 28 years. Ann. intern. Med. 53, 861–876 (1960).
Duvoisin, G.E., Brandenburg, R.O., Mcgoon, D.C.: Factors affecting thromboembolism associated with prosthetic heart valves. Circulation 36, Suppl. I, 1–70 (1967).
Ebbe, S.: Thrombopoietin. Blood 44, 605–608 (1974).
Ebbe, S., Stohlman, F. Jr.: Megakaryocytopoiesis in the rat. Blood 26, 20–35 (1965).
Ebbe, S., Stohlman, F. Jr., Donovan, J., Howard,D.: Platelet survival in the rat as measured with tritium-labeled diisopropylfluorophosphate. J. Lab. clin. Med. 68, 233–243 (1966).
Ebbe, S., Wittels, B., Dameshek, W.: Autoimmune thrombocytopenic purpura (“ITP” type) with chronic lymphocytic leukemia. Blood 19, 23–37 (1962).
Emrich, D.: Nuklearmedizinische Funktionsdiagnostik. Stuttgart: Thieme 1971.
Eurenius, K., Mortensen, R.F., Meserol, P.M., Curreri, P.W.: Platelet and megakaryocyte kinetics following thermal injury. J. Lab. clin. Med. 79, 247–257 (1972).
Evatt, B.L., Levin, J.: Detection of thrombopoietic activity by an isotopic method. Clin. Res. 16, 302 (1968).
Evatt, B.L., Levin, J.: Measurement of thrombopoiesis in rabbits using 75selenomethionine. J. clin. Invest. 48, 1615–1626 (1969).
Fanconi, G.: Die familiäre Panmyelopathie. Schweiz. med. Wschr. 94, 1309–1318 (1964).
Ferguson, J.C., Mackay, N., Philip, J.A.D., Summer, D.J.: Platelet and fibrinogen kinetic studies in diabetes mellitus. Brit. J. Haemat. 25, 545 (1973).
Fickers, M., Speck, B.: Thrombocythaemia. Acta haemat. (Basel) 51, 257–265 (1974).
Firkin, B.G., Williams, W.J.: The incorporation of radioactive phosphorus into phospholipide of human leukemic leukocytes and platelets. J. clin. Invest. 40, 423–432 (1961).
Gehrmann, G.: Thrombozytenkinetik und Splenektomie. Blut 25, 229–234 (1972).
Gehrmann, G.: Blutplättchenkinetik beim Morbus Werlhof und bei Hypersplenismus. Nucl.-Med. (Stuttg.) Suppl. 11, 55–58 (1973a).
Gehrmann, G.: Thrombocytenkinetik bei lymphoproliferativen Erkrankungen. Verh. dtsch. Ges. inn. Med. 79, 523–524 (1973b).
Goldschmidt, B., Sarkady, B., Gardos, G., Mathary, A.: Platelet production and survival in cyanotic congenital heart disease. Scand. J. Haemat. 13, 110–115 (1974).
Harker, L.A.: Megakaryocyte quantitation. J. clin. Invest. 47, 452–457 (1968a).
Harker, L.A.: Kinetics of thrombopoiesis. J. clin. Invest. 47, 458–465 (1968b).
Harker, L.A.: Thrombokinetics in idiopathic thrombocytopenic purpura. Brit. J. Haemat. 19, 95–104 (1970).
Harker, L.A., Finch, C.A.: Thrombokinetics in man. J. clin. Invest. 48, 963–974 (1969).
Harker, L.A., Slichter, S.J.: Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. New Engl. J. Med. 283, 1302–1305 (1970).
Harker, L.A., Slichter, S.J.: Arterial and Venous Thromboembolism: Kinetic Characterization and Evaluation of Therapy. Thrombos. Diathes. haemorrh. (Stuttg.) 31, 188–203 (1974).
Harrington, W.J., Minnich, V., Hollingsworth,J., Moore, C.V.: Demonstration of thrombocytopenic factor in blood of patients with thrombocytopenic purpura. J. Lab. clin. Med. 38, 1–10 (1951).
Heck, J., Gehrmann, G.: Plättchenkinetik bei chronischem Alkoholismus. Dtsch. med. Wschr. 98, 2123–2126 (1973).
Heck, J., Gehrmann, G.: Thrombozytopenie bei Herzinsuffizienz. Z. Kardiol. 63, 911–915 (1974).
Heck, J., Gehrmann, G.: Lienale Plättchenspeicherung und Splenektomie bei lymphoproliferativen Hämoblastosen. Med. Welt 26, 1704–1705 (1975).
Heilmeyer, L.: Rapports physiologiques entre la rate et la moelle osseuse. Rev. Hémat. 9, 267–290 (1954).
Hirsch, E.O., Dameshek, W.: “Idiopathic” thrombocytopenia: review of 89 cases with particular reference to differentiation and treatment of acute (self-limited) and chronic types. Arch. intern. Med. 88, 701–728 (1951).
Hovig. T.: The ultrastructure of blood platelets in normal and abnormal states. Ser. Haemat. 2, 3–64 (1968).
Hughes-Jones, N.C., Szur, L.: Determination of the sites of red-cell destruction using 51Cr-labeled cells. Brit. J. Haemat. 3, 320–331 (1957).
Huth, K., Reimers, H.J., Schmahl, F.W.: Thrombozytenumsatz bei unterschiedlichen Hyperlipoproteinämieformen mit und ohne koronare Herzkrankheit. Thrombos. Diathes. haermorrh. (Stuttg.) Suppl. 52, 137–142 (1972).
Jonker, J.J., Veen, M.R., Schopman, W., Denottolander, G.J.G.: Platelet survival time in angina pectoris and hyperlipoproteinaemia. Thromb. Res. 4, 65–67 (1974).
Karpatkin, S.: Drug-induced thrombocytopenia. Amer. J. med. Sci. 262, 68–78 (1971).
Karpatkin, S., Garg, S.K., Freedman, M.L.: Role of iron as a regulator of thrombopoiesis. Amer. J. Med. 57, 521–525 (1974).
Karpatkin, S., Siskind, G.W.: In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood 33, 795–812 (1969).
Karpatkin, S., Strick, N., Karpatkin, M.B., Siskind, G.W.: Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Amer. J. Med. 52, 776–785 (1972a).
Karpatkin, S., Strick, N., Siskind, G.W.: Detection of splenic anti-Platelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP). Brit. J. Haemat. 23, 167–176 (1972b).
Katz, J., Krawitz, S., Sacks, P.V., Levin, S.E., Thomson, P., Levin, J., Metz, J.: Platelet, erythrocyte, and fibrinogen kinetics in the hemolytic-uremic syndrome of infancy. J. Pediat. 83, 739–748 (1973).
Kelemen, E., Cserhati, I.Tangs, B.: Demonstration and some properties of human thrombopoietin in thrombocythaemic sera. Acta haemat. (Basel) 20, 350–355 (1958).
Khilanani, R., Alsarraf, M.: The association of autoimmune thrombocytopenia and Hodgkin’s disease. Oncology 28 238–245 (1973).
Kinosita, R., Ohno, S.: Biodynamics of thrombopoesis. In: Henry Ford Hospital Symposium on Blood Platelets. Boston: Little Brown 1961.
Klinda, F., Hrubisko, M.: Lebensdauer der Thrombozyten und Bestimmung ihres Abbauortes bei Thrombozytopenien. Haematologia (Budap.) 2, 337–347 (1968).
Kotilainen, M.: Platelet kinetics in normal subjects and in haematological disorders; with special reference to thrombocytopenia and to the role of the spleen. Scand. J. Haemat. Suppl. 5 (1969).
Kummer, H.: Untersuchungen zu Kinetik und Funktion der Thrombozyten. Helv. med. Acta Suppl. 53 (1972).
Kummer, H., Egger, G.: Pathogenese der Thrombopenie bei Leberzirrhose. Schweiz. med. Wschr. 101, 1816–1817 (1971).
Kummer, H., Hunziker, H.R., Althaus, U.: Medikamentöse Beeinflussung des Thrombozytenumsatzes bei Patienten mit künstlichen Herzklappen. Schweiz. med. Wschr. 104, 142–144 (1974).
Kutti, J. Weinfeld, A.: Platelet survival in man. Scand. J. Haemat. 8 336–346 (1971a).
Kutti, J.Weinfeld. A.: Platelet survival in active polycythaemia vera with reference to the heamatocrit level. Scand. J. Haemat. 8 405–414 (1971b).
Kutti, J., Weinfeld, A., Westin, J.: The relationship between platelet pool and spleen size. Scand. J. Haemat. 9, 351–354 (1972).
Leeksma, C.H.W., Cohen. J.A.: Determination of the life span of human blood platelets using labeled diisopropylfluorophosphonate. J. clin. Invest. 35, 964 (1956).
Levin, J., Conley, C.L.: Thrombocytosis associated with malignant disease. Arch. intern. Med. 114, 497–500 (1964).
Levy, R.N., Sawitsky, A., Florman, A.L., Rubin,E.: Fatal aplastic anemia after hepatitis. Report of five cases. New Engl. J. Med. 273, 1118–1123 (1965).
Ljungquist, U.: Platelets in shock and trauma. J. surg. Res. 15, 132–162 (1973).
Lohrmann, H.-P.: Differentialdiagnose der Thrombozytopenien. Dtsch. med. Wschr. 100, 2492–2494 (1975).
Majsk, A., Fortnova, J., Vopatova, M.: (Aerlebenszeit and Vorkommen von Thrombozytenantikörpern bei Thrombozytopenien. Folia haemat. (Lpz.) 99, 360–366 (1973).
Manohitharajah, S.M., Rahman, A.N., Donnelly, R.J., Deverall, P.B., Watson, D.A.: Platelet survival in patients with homograft and prosthetic heart valves. (Correlation with incidence of thromboembolism). Thorax 29, 639–642 (1974).
Mcgehee, W.G., Rapaport, S.I., Hjort, P.F.: Intravascular coagulation in fulminant meningoccemia. Ann. intern. Med. 67. 250–260 (1967).
Mckay, D.G.: Disseminated intravascular coagulation. Pathology, diagnosis and therapy of disseminated intravascular coagulation. Proc. Roy. Soc. Med. 61, 1129–1134 (1968).
Mckay, D.G., Margaretten W.: Disseminated intravascular coagulation in virus diseases. Arch. intern. Med. 120, 129–152 (1967).
Mcmillan, R., Longmire, R., Yelenosky, R., Craddock, C.G.: Platelet-binding antibodies produced in vitro by idiopathic thrombocytopenic purpura (ITP) spleens. J. clin. Invest. 50, 65a (1971).
Mcmillan, R., Longmire, R.L., Yelenosky, R., Donnell. R.L., Armstrong, S.: Quantitation of platelet-binding Ig G produced in vitro by spleens From patients with idiopathic thrombocytopenic purpura. New Engl. J. Med. 291, 812–817 (1974).
Miescher, P.A.: Drug-induced thrombocytopenia. Se-min. Haemat. 10, 311–325 (1973).
Mourad, N.: A simple method for obtaining platelet concentration Free of aggregates. Transfusion 8, 48 (1968).
Von Mühlenen, A., Kummer, H., Bucher, U.: Be stimmung der Thrombozytenlebenszeit mit 51Cr. Methodik und klinische Anwendung in der Abklä- Schweiz. med.Wschr. 98, 1731–1739 (1968).
Mueller-Eckhardt, C.: Immunthrombopenie. Med. Welt 25, 1575–1580 (1974).
Murphy, E.A., Mustard, J.F.: Coagulation tests and platelet economy in atherosclerotic and control subjects. Circulation 25, 114–125 (1962).
Murphy, E.A., Robinson, G.A., Rowsell, H.C., Mustard, J.F.: The pattern of platelet disappearance. Blood 30, 26–38 (1967).
Murphy, S., Sayar, S.N., Gardner, F.H.: Storage of platelet concentrates at 22 degrees C. Blood 35, 549–557 (1970).
Najean, Y., Ardaillou, N.: The use of 75Se-Methionine for the in vivo Study of Platelet Kinetics. Scand. J. Haemat. 6, 395–401 (1969).
Najean,Y., Ardaillou, N.: The sequestration site of platelet in idiopathic thrombocytopenic purpura: its correlation with the results of splenectomy. Brit. J. Haemat. 21, 153–164 (1971).
Najean, Y., Ardaillou, N., Caen, J., Larrieu, M.J., Bernhard, J.: Survival of radiochromium-labeled platelets in thrombocytopenias. Blood 22, 718–732 (1963).
Najean, Y., Ardaillou, N., Dresch, C., Bernard,J.: The platelet destruction site in thrombocytopenic purpuras. Brit. J. Haemat. 13, 409–426 (1967).
Odell, T.T. Jr., Jackson, C.W., Reiter, R.S.: Depression of the megakaryocyte-platelet system in rats by transfusion of platelets. Acta haemat. (Basel) 38, 34–42 (1967).
Odell, T.T. Jr., Mcdonald, T.P.: Two mechanisms of sulfate-S35 uptake by blood platelets of rats. Amer. J. Physiol. 206, 580–584 (1964).
Odell, T.T. Jr., Mcdonald, T.P., Detwiler, T.C.: Stimulation of platelet production by serum of platelet-depleted rats. Proc. Soc. Exp. Biol. Med. 108, 428–431 (1961).
Oldham, R.K., Larson, S.M., Givelber, H.M.G., Chretien, P.B., Johnson, R.E.: A preliminary study of 51Cr-labeled platelets for evaluation of splenic sequestration in chronic lymphocytic leukemia. J. nucl. Med. 14, 219–222 (1973).
O’neill, B., Firkin, B.: Platelet survival studies in coagulation disorders, thrombocytopenia, and conditions associated with atherosclerosis. J. Lab. clin. Med. 64, 188–201 (1964).
Paulus, J.M.: Platelet kinetics: radioisotopic, cytological, mathematical, and clinical aspects, Vol. 2. Amsterdam: North Holland Pub. 1971.
Paulus, J.M., Fillet, G., Thompson, K.H., Willems,J.: Interprétation mâthematique de l’étude de la durée de vie des plaquettes marquées au chrome radio-actif. Nouv. Rev. Franc. Hémat. 9, 886–888 (1969a).
Paulus, J.M., Thompson, K.H.: Computer analysis of platelet survival curves. Blood 34, 529–530 (1969b).
Pawelski, S., Rudowski, W., Rechnovicz, K., Zdziechowska, H., Konopka, L., Kotelba-Witkowska, B., Klave, Z., Nowadz, S.: The effect of splenectomy on the clinical picture and survival time of platelets in thrombocytopenia. Folia haemat. (Lpz.) 3, 304–307 (1971).
Penington, D.G.: Assessment of platelet production with 75Se selenomethionine. Brit. Med. J. 4, 782–784 (1969).
Penington, D.G.: Isotope bioassay for “thrombopoietin”. Brit. Med. J. 1, 606–608 (1970).
Penny, R., Rozenberg, M.C., Firkin, B.G.: The splenic platelet pool. Blood 27, 1–16 (1966).
Rabinowitz, Y., Dameshek, W.: Systemic lupus erythematosus after “ idiopathic” thrombocytopenic purpura: a review. Ann. intern. Med. 52, 1–28 (1960).
Reisner, E.H., Keating, R.P., Friesen, C., Loeffler, E.: Survival of sodium chromate 51 labeled platelets in animals and man. Proc. 6th Congr. Int. Soc. Haemat. Boston. New York: Grune & Stratton 1958.
Ries, C.A., Price, D.C.: 51Cr-platelet kinetics in thrombocytopenia. Correlation between splenic sequestration of platelets and response to splenectomy. Ann. intern. Med. 80, 702–707 (1974).
Seidl, S.: Die Thrombozytentransfusion; Untersuchungen mit radioaktiv markierten Thrombozyten. Stuttgart: Gustav Fischer 1968.
Selroos, O.: Thrombocytosis. Acta med. scand. 193, 431–436 (1973).
Shulman, N.R., Marder, V.J., Hiller, M.C., Collier, E.M.: Platelet and leukocyte isoantigens and their antibodies: serologic, physiologic and clinical studies. Progr. Haemat. 4, 222–304 (1964).
Slichter, S.J., Harker, L.A.: Hemostasis in malignancy. Ann. N.Y. Acad. Sci. 230, 252–261 (1974).
Solomon, R.B., Clatanoff, D.V.: Platelet survival studies and body scanning in idiopathic thrombocytopenic purpura. Amer. J. med. Sci. 254, 777–784 (1967).
Spicer, S.S., Greene, W.B., Hardin, J.H.: Ultra-structural localization of acid mucosubstance and antimonate-precipitable cation in human and rabbit platelets and megakaryocytes. J. Histochem. Cytochem. 17, 781–792 (1969).
Steele, P., Ellis, J.H., Genton, E.: Platelet survival time in severe chronic airway obstruction. Chest 67, Suppl. 2, 46–47 (1975a).
Steele, P., Weily, H., Davies, H., Pappas, G., Genton, E.: Platelet survival time following aortic valve replacement. Circulation 51, 358–362 (1975b).
Stobbe, H.: Indikation zur Splenektomie aus internistisch-hämatologischer Sicht. Zbl. Chir. 99, 1153–1163 (1974).
Stossel, T.P., Levy, R.: Intravascular coagulation associated with pneumococcal bacteriemia and symmetrical peripheral gangrene. Arch. intern. Med. 125, 876–878 (1970).
Stuart, M., Stockman, J., Murphy, S., Schut, L., Ames, M., Urmson, J., Oslo, F.: Shortened platelet lifespan in patients with hydrocephalus and ventriculojugular shunts: results of preliminary attempts at correction. J. Pediat. 80, 21–25 (1972).
Sullivan, L.W., Lin, Y.K., Talarico, L., Emerson, C.P.: Alcohol-induced thrombocytopenia in man. J. clin. Invest. 47, 95a (1968).
Tsukada, T., Steiner, M., Baldini, M.G.: Chromium 51 uptake as a function of platelet age. Scand. J. Haemat. 8, 270–275 (1971).
Uchida, T., Yasunaga, K., Kariyone, S., Wakisaka, G.: Survival and sequestration of 51Cr-and 99TcO4-labeled platelets. J. nucl. Med. 15, 801–807 (1974).
Vodopick, H., Rupp, E.M., Edwards, C.L., Goswitz, F.A., Beauchamp, J.J.: Spontaneous cyclic leukocytosis and thrombocytosis in chronic granulocytic leukemia. New Engl. J. Med. 286, 284–290 (1972).
Welly, H.S., Genton, E.: Altered platelet function in patients with prosthetic mitral valves; effect of sulfinpyrazone therapy. Circulation 42, 967–972 (1970).
Weily, H.S., Steele, P.P., Genton, E.: Platelet survival in patients with a Beall valve: Relation to low incidence of thromboembolism. Amer. J. Cardiol. 30, 229–231 (1972).
White, J.G.: The dense bodies of human platelets.–Origin of serotonin storage particles From platelet granules. Amer. J. Path. 53, 791–808 (1968).
White, J.G.: Platelet morphology. In: The circulating platelet (Ed. S.A. Johnson ). New York: Academic Press 1971.
White, J.G., Heagan, B.: Mucopolysaccharides in platelet granules. Fed. Proc. 29, 623 (1970).
Wintrobe, M.M.: Clinical Hematology. 7th ed. Philadelphia: Lea & Febinger 1974.
Yamada, E.: The fine structure of the megakaryocyte in the mouse spleen. Acta anat. (Basel) 29, 267–290 (1957).
Zucker, M.B., Hellman, L., Zumoff, B.: Rapid disappearance of C14-labeled serotonin From platelets in patients with carcinoid syndrome. J. Lab. clin. Med. 63, 137–146 (1964).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Mariß, P. (1978). Thrombozytäres System. In: Hundeshagen, H. (eds) Nuklearmedizin / Nuclear Medicine. Handbuch der Medizinischen Radiologie / Encyclopedia of Medical Radiology, vol 15 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81170-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-81170-8_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81171-5
Online ISBN: 978-3-642-81170-8
eBook Packages: Springer Book Archive